Muhammad Karyana

机构：Pertamina (Indonesia), Kementerian Kesehatan Republik Indonesia · ORCID：0000-0002-7785-5731

发表论文 95 篇 · 总被引 2415 次 · h-index 21

代表论文

• Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial (2024 · The Lancet HIV · 被引 31)
• Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia (2023 · Frontiers in Medicine · 被引 20)
• Characteristics of Drug-sensitive and Drug-resistant Tuberculosis Cases among Adults at Tuberculosis Referral Hospitals in Indonesia (2022 · American Journal of Tropical Medicine and Hygiene · 被引 13)
• Epidemiologic, clinical, and serum markers may improve discrimination between bacterial and viral etiologies of childhood pneumonia (2023 · Frontiers in Medicine · 被引 10)
• Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE) (2022 · PLoS ONE · 被引 9)
• Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies (2022 · Heliyon · 被引 7)